vs

Side-by-side financial comparison of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) and WESTWOOD HOLDINGS GROUP INC (WHG). Click either name above to swap in a different company.

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is the larger business by last-quarter revenue ($44.6M vs $25.0M, roughly 1.8× WESTWOOD HOLDINGS GROUP INC). WESTWOOD HOLDINGS GROUP INC runs the higher net margin — 3.1% vs -90.4%, a 93.6% gap on every dollar of revenue. On growth, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. posted the faster year-over-year revenue change (13.8% vs 7.4%). Over the past eight quarters, PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s revenue compounded faster (7.3% CAGR vs 4.9%).

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

Westwood Studios, Inc. was an American video game developer based in Las Vegas, Nevada. It was founded by Brett Sperry and Louis Castle in 1985 as Brelous Software, but got changed after 2 months into Westwood Associates and was renamed to Westwood Studios when Virgin Games bought the company in 1992. The company was bought by Electronic Arts alongside Virgin Interactive's North American operations in 1998. In January 2003, it was announced that Westwood, alongside Westwood Pacific, would be ...

PACB vs WHG — Head-to-Head

Bigger by revenue
PACB
PACB
1.8× larger
PACB
$44.6M
$25.0M
WHG
Growing faster (revenue YoY)
PACB
PACB
+6.4% gap
PACB
13.8%
7.4%
WHG
Higher net margin
WHG
WHG
93.6% more per $
WHG
3.1%
-90.4%
PACB
Faster 2-yr revenue CAGR
PACB
PACB
Annualised
PACB
7.3%
4.9%
WHG

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
PACB
PACB
WHG
WHG
Revenue
$44.6M
$25.0M
Net Profit
$-40.4M
$782.0K
Gross Margin
37.1%
Operating Margin
-92.3%
Net Margin
-90.4%
3.1%
Revenue YoY
13.8%
7.4%
Net Profit YoY
-1802.7%
EPS (diluted)
$-0.11
$0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PACB
PACB
WHG
WHG
Q1 26
$25.0M
Q4 25
$44.6M
$27.1M
Q3 25
$38.4M
$24.3M
Q2 25
$39.8M
$23.1M
Q1 25
$37.2M
$23.3M
Q4 24
$39.2M
$46.5M
Q3 24
$40.0M
$23.7M
Q2 24
$36.0M
$22.7M
Net Profit
PACB
PACB
WHG
WHG
Q1 26
$782.0K
Q4 25
$-40.4M
$1.8M
Q3 25
$-38.0M
$3.7M
Q2 25
$-41.9M
$1.0M
Q1 25
$-426.1M
$478.0K
Q4 24
$2.4M
$3.7M
Q3 24
$-60.7M
$-1.2M
Q2 24
$-173.3M
$-378.0K
Gross Margin
PACB
PACB
WHG
WHG
Q1 26
Q4 25
37.1%
Q3 25
41.4%
Q2 25
36.9%
Q1 25
-3.7%
Q4 24
25.6%
Q3 24
25.0%
Q2 24
16.5%
Operating Margin
PACB
PACB
WHG
WHG
Q1 26
Q4 25
-92.3%
8.0%
Q3 25
-101.1%
8.3%
Q2 25
-112.8%
3.8%
Q1 25
-1154.5%
-0.3%
Q4 24
-390.1%
10.0%
Q3 24
-160.3%
-2.1%
Q2 24
-488.3%
-18.4%
Net Margin
PACB
PACB
WHG
WHG
Q1 26
3.1%
Q4 25
-90.4%
6.8%
Q3 25
-98.9%
15.4%
Q2 25
-105.4%
4.5%
Q1 25
-1146.8%
2.1%
Q4 24
6.0%
14.5%
Q3 24
-151.9%
-5.0%
Q2 24
-481.3%
-1.7%
EPS (diluted)
PACB
PACB
WHG
WHG
Q1 26
$0.09
Q4 25
$-0.11
$0.21
Q3 25
$-0.13
$0.41
Q2 25
$-0.14
$0.12
Q1 25
$-1.44
$0.05
Q4 24
$-0.44
$0.45
Q3 24
$-0.22
$-0.15
Q2 24
$-0.64
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PACB
PACB
WHG
WHG
Cash + ST InvestmentsLiquidity on hand
$279.5M
$23.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$5.3M
$126.1M
Total Assets
$784.1M
$150.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PACB
PACB
WHG
WHG
Q1 26
$23.4M
Q4 25
$279.5M
$47.7M
Q3 25
$298.7M
$41.3M
Q2 25
$314.7M
$35.2M
Q1 25
$343.1M
$29.1M
Q4 24
$389.9M
$46.5M
Q3 24
$471.1M
$48.3M
Q2 24
$509.8M
$44.1M
Stockholders' Equity
PACB
PACB
WHG
WHG
Q1 26
$126.1M
Q4 25
$5.3M
$125.6M
Q3 25
$36.1M
$123.9M
Q2 25
$61.5M
$122.4M
Q1 25
$91.6M
$121.4M
Q4 24
$506.6M
$120.3M
Q3 24
$453.1M
$120.4M
Q2 24
$492.7M
$120.5M
Total Assets
PACB
PACB
WHG
WHG
Q1 26
$150.4M
Q4 25
$784.1M
$162.3M
Q3 25
$803.2M
$154.0M
Q2 25
$825.5M
$146.3M
Q1 25
$860.8M
$135.0M
Q4 24
$1.3B
$150.0M
Q3 24
$1.5B
$151.5M
Q2 24
$1.5B
$147.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PACB
PACB
WHG
WHG
Operating Cash FlowLast quarter
$-19.1M
$-2.6M
Free Cash FlowOCF − Capex
$-19.9M
FCF MarginFCF / Revenue
-44.6%
Capex IntensityCapex / Revenue
1.9%
Cash ConversionOCF / Net Profit
-3.28×
TTM Free Cash FlowTrailing 4 quarters
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PACB
PACB
WHG
WHG
Q1 26
$-2.6M
Q4 25
$-19.1M
$18.9M
Q3 25
$-18.7M
$8.5M
Q2 25
$-29.4M
$7.3M
Q1 25
$-44.1M
$-4.9M
Q4 24
$-30.6M
$21.1M
Q3 24
$-45.5M
$529.0K
Q2 24
$-54.3M
$3.6M
Free Cash Flow
PACB
PACB
WHG
WHG
Q1 26
Q4 25
$-19.9M
$18.8M
Q3 25
$-18.8M
$8.5M
Q2 25
$-29.9M
Q1 25
$-45.4M
$-4.9M
Q4 24
$-32.3M
$21.0M
Q3 24
$-46.3M
$519.0K
Q2 24
$-55.7M
$3.5M
FCF Margin
PACB
PACB
WHG
WHG
Q1 26
Q4 25
-44.6%
69.5%
Q3 25
-48.9%
34.8%
Q2 25
-75.3%
Q1 25
-122.3%
-21.1%
Q4 24
-82.3%
45.2%
Q3 24
-115.7%
2.2%
Q2 24
-154.8%
15.6%
Capex Intensity
PACB
PACB
WHG
WHG
Q1 26
Q4 25
1.9%
0.3%
Q3 25
0.2%
0.3%
Q2 25
1.4%
0.0%
Q1 25
3.7%
0.0%
Q4 24
4.1%
0.2%
Q3 24
2.0%
0.0%
Q2 24
4.1%
0.1%
Cash Conversion
PACB
PACB
WHG
WHG
Q1 26
-3.28×
Q4 25
10.29×
Q3 25
2.29×
Q2 25
7.08×
Q1 25
-10.25×
Q4 24
-12.93×
5.69×
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

WHG
WHG

Asset-based$19.3M77%
Trust fees$5.3M21%

Related Comparisons